Qube Research & Technologies LTD Burning Rock Biotech LTD Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$17.37 - $27.92 $135,451 - $217,720
-7,798 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$26.14 - $37.45 $59,756 - $85,610
-2,286 Reduced 22.67%
7,798 $230,000
Q1 2021

May 14, 2021
SELL
$23.5 - $39.58 $172,372 - $290,319
-7,335 Reduced 42.11%
10,084 $271,000
Q4 2020

Feb 16, 2021
BUY
$22.55 - $30.87 $392,798 - $537,724
17,419 New
17,419 $402,000

Others Institutions Holding BNR

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Burning Rock Biotech Ltd

BNR Quotes by TradingView
  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $705M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email